CHOLESTYRAMINE

CHOLESTYRAMINE was reported 12225 times

CHOLESTYRAMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INTESTINAL INTRAEPITHELIAL LYMPHOCYTES INCREASED 13 0.1940
1 MICROVILLOUS INCLUSION DISEASE 13 0.1733
2 PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME 19 0.1338
3 ALVEOLAR LUNG DISEASE 20 0.1053
4 PROBIOTIC THERAPY 10 0.1010
5 GASTROINTESTINAL ANASTOMOTIC STENOSIS 9 0.0947
6 CRYPTITIS 13 0.0935
7 FOREIGN BODY IN MOUTH 9 0.0900
8 BILE ACID MALABSORPTION 23 0.0816
9 BILE ACIDS INCREASED 11 0.0621
10 APOPTOSIS 14 0.0453
11 PRODUCT SOLUBILITY ABNORMAL 184 0.0364
12 LAPAROTOMY 13 0.0284
13 POST PROCEDURAL DIARRHOEA 14 0.0275
14 SHORT-BOWEL SYNDROME 17 0.0261
15 GASTROINTESTINAL STOMA OUTPUT INCREASED 12 0.0256
16 PRODUCT PHYSICAL CONSISTENCY ISSUE 135 0.0244
17 ANASTOMOTIC ULCER 11 0.0239
18 INTESTINAL ANASTOMOSIS 15 0.0233
19 TERMINAL ILEITIS 14 0.0228
20 FAECAL VOLUME DECREASED 10 0.0208
21 THYROTOXIC CRISIS 22 0.0193
22 DIFFUSE ALVEOLAR DAMAGE 20 0.0174
23 GASTROINTESTINAL WALL THICKENING 26 0.0174
24 FAECAL CALPROTECTIN INCREASED 55 0.0174
25 EROSIVE DUODENITIS 13 0.0163
26 STOMA COMPLICATION 15 0.0148
27 THERAPEUTIC REACTION TIME DECREASED 41 0.0140
28 ILEAL STENOSIS 22 0.0124
29 SMALL INTESTINAL STENOSIS 13 0.0122
30 PRODUCT TASTE ABNORMAL 163 0.0120
31 FOETAL HEART RATE ABNORMAL 11 0.0119
32 FOREIGN BODY IN THROAT 36 0.0114
33 ENTEROCUTANEOUS FISTULA 10 0.0113
34 VASCULAR DEVICE INFECTION 51 0.0112
35 CHOLANGITIS SCLEROSING 23 0.0112
36 INTESTINAL STENOSIS 47 0.0111
37 MESENTERIC VEIN THROMBOSIS 11 0.0110
38 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 10 0.0108
39 BIOPSY 10 0.0108
40 CEREBRAL VENOUS SINUS THROMBOSIS 9 0.0107
41 COLITIS MICROSCOPIC 50 0.0105
42 ANAL FISSURE 56 0.0104
43 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 11 0.0104
44 GASTRIC POLYPS 22 0.0097
45 STREPTOCOCCAL BACTERAEMIA 10 0.0092
46 HYPERPARATHYROIDISM SECONDARY 23 0.0092
47 SACROILIITIS 17 0.0090
48 GASTROINTESTINAL STOMA COMPLICATION 14 0.0089
49 DUODENITIS 27 0.0088
50 PRODUCT RESIDUE PRESENT 45 0.0083
51 ABDOMINAL ADHESIONS 26 0.0082
52 PROCTALGIA 51 0.0079
53 DRUG LEVEL ABOVE THERAPEUTIC 36 0.0079
54 ABDOMINAL RIGIDITY 21 0.0077
55 FOREIGN BODY IN RESPIRATORY TRACT 10 0.0076
56 BLOOD ELECTROLYTES ABNORMAL 9 0.0073
57 NEPHROGENIC ANAEMIA 33 0.0071
58 INFUSION SITE DISCHARGE 12 0.0068
59 SPRUE-LIKE ENTEROPATHY 33 0.0067
60 ABDOMINAL HERNIA 30 0.0066
61 ISCHAEMIC HEPATITIS 9 0.0066
62 INTESTINAL RESECTION 35 0.0065
63 LARGE INTESTINE POLYP 44 0.0063
64 EOSINOPHILIC PNEUMONIA 20 0.0063
65 PRODUCT USE COMPLAINT 98 0.0062
66 COSTOCHONDRITIS 10 0.0061
67 SMALL INTESTINAL OBSTRUCTION 74 0.0060
68 FREQUENT BOWEL MOVEMENTS 159 0.0059
69 ILEOSTOMY 15 0.0059
70 OROPHARYNGEAL DISCOMFORT 53 0.0059
71 CHOLESTATIC LIVER INJURY 13 0.0058
72 PRODUCT PACKAGING DIFFICULT TO OPEN 15 0.0057
73 POOR VENOUS ACCESS 59 0.0057
74 ERYTHEMA NODOSUM 20 0.0057
75 FAECES SOFT 41 0.0056
76 ENTERITIS 36 0.0056
77 DRUG LEVEL BELOW THERAPEUTIC 31 0.0056
78 DRUG LEVEL DECREASED 57 0.0056
79 FISTULA 62 0.0055
80 LYMPHOCYTE COUNT INCREASED 18 0.0055
81 LARGE INTESTINAL STENOSIS 11 0.0055
82 INTESTINAL POLYP 9 0.0055
83 HYPOVOLAEMIA 32 0.0055
84 BLOOD MAGNESIUM DECREASED 47 0.0054
85 CLOSTRIDIUM TEST POSITIVE 12 0.0054
86 RENAL MASS 11 0.0053
87 REBOUND ACID HYPERSECRETION 16 0.0053
88 BILE DUCT OBSTRUCTION 10 0.0053
89 CHOKING SENSATION 29 0.0053
90 HEPATIC FIBROSIS 18 0.0052
91 PLASMA CELL MYELOMA RECURRENT 17 0.0052
92 MALABSORPTION 27 0.0052
93 CROHN'S DISEASE 35 0.0051
94 ESCHERICHIA BACTERAEMIA 12 0.0051
95 HYPERVOLAEMIA 25 0.0051
96 ANORECTAL DISORDER 10 0.0050
97 ANAL INCONTINENCE 45 0.0050
98 VARICES OESOPHAGEAL 15 0.0050
99 CLOSTRIDIUM DIFFICILE COLITIS 52 0.0049
100 ABNORMAL FAECES 40 0.0049
101 CLOSTRIDIUM DIFFICILE INFECTION 103 0.0047
102 ESCHERICHIA URINARY TRACT INFECTION 20 0.0047
103 PRODUCT ODOUR ABNORMAL 49 0.0047
104 DIVERTICULUM 33 0.0046
105 GASTROINTESTINAL OBSTRUCTION 11 0.0046
106 SERUM FERRITIN INCREASED 24 0.0045
107 ANAL FISTULA 24 0.0045
108 INTESTINAL OBSTRUCTION 167 0.0044
109 INFREQUENT BOWEL MOVEMENTS 11 0.0044
110 FUNCTIONAL GASTROINTESTINAL DISORDER 15 0.0043
111 BOWEL MOVEMENT IRREGULARITY 33 0.0043
112 APHTHOUS ULCER 33 0.0043
113 ABDOMINAL TENDERNESS 21 0.0042
114 HYPERAMMONAEMIA 21 0.0042
115 HEPATIC ENCEPHALOPATHY 39 0.0042
116 INFUSION SITE BRUISING 9 0.0042
117 DEFAECATION URGENCY 29 0.0041
118 ANORECTAL DISCOMFORT 22 0.0041
119 ABDOMINAL MASS 11 0.0041
120 INTRAVENTRICULAR HAEMORRHAGE 10 0.0040
121 IRON DEFICIENCY 18 0.0040
122 CHOLECYSTITIS INFECTIVE 11 0.0040
123 GASTROINTESTINAL INFLAMMATION 31 0.0040
124 VITAMIN B12 DEFICIENCY 16 0.0039
125 LACTOSE INTOLERANCE 10 0.0039
126 ANAL ABSCESS 21 0.0039
127 COLITIS 143 0.0038
128 MALNUTRITION 42 0.0038
129 RETCHING 80 0.0037
130 COLECTOMY 21 0.0037
131 HEPATIC STEATOSIS 69 0.0037
132 INFUSION SITE EXTRAVASATION 23 0.0037
133 EAR CONGESTION 10 0.0037
134 LARGE INTESTINAL ULCER 10 0.0037
135 HYPERTHYROIDISM 53 0.0037
136 DIVERTICULUM INTESTINAL 16 0.0037
137 BLOOD PRESSURE DIASTOLIC DECREASED 27 0.0037
138 INFUSION SITE HAEMORRHAGE 12 0.0036
139 HAEMORRHOIDS 71 0.0036
140 GASTROINTESTINAL SOUNDS ABNORMAL 18 0.0036
141 PROSTATOMEGALY 14 0.0036
142 LABYRINTHITIS 9 0.0036
143 RENAL CYST 28 0.0035
144 PANCREATIC CARCINOMA METASTATIC 10 0.0035
145 MUSCULOSKELETAL CHEST PAIN 54 0.0035
146 HAEMORRHOIDAL HAEMORRHAGE 17 0.0035
147 BODY TEMPERATURE DECREASED 34 0.0035
148 HIATUS HERNIA 44 0.0034
149 METABOLIC ENCEPHALOPATHY 10 0.0033
150 IRRITABLE BOWEL SYNDROME 71 0.0033
151 PRODUCT SUBSTITUTION ISSUE 187 0.0032
152 PANCREATIC DISORDER 16 0.0032
153 ILEUS 40 0.0032
154 SEASONAL ALLERGY 45 0.0032
155 INFUSION SITE SWELLING 20 0.0032
156 ABDOMINAL ABSCESS 14 0.0032
157 HYPOMAGNESAEMIA 44 0.0032
158 BILE DUCT STONE 10 0.0031
159 DIARRHOEA HAEMORRHAGIC 29 0.0031
160 BILIARY COLIC 9 0.0031
161 WEIGHT FLUCTUATION 32 0.0031
162 BLOOD PRESSURE DIASTOLIC INCREASED 14 0.0030
163 SPONDYLITIS 11 0.0030
164 LOW BIRTH WEIGHT BABY 24 0.0030
165 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 165 0.0030
166 HEPATIC LESION 13 0.0030
167 HEPATITIS CHOLESTATIC 18 0.0030
168 CHOLECYSTECTOMY 34 0.0030
169 CLOSTRIDIAL INFECTION 10 0.0030
170 SOCIAL PROBLEM 12 0.0029
171 CHOLELITHIASIS 95 0.0029
172 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 11 0.0029
173 HEPATIC CIRRHOSIS 54 0.0029
174 VITAMIN D DEFICIENCY 28 0.0029
175 IMPAIRED GASTRIC EMPTYING 39 0.0029
176 FLATULENCE 162 0.0029
177 INFUSION SITE PRURITUS 9 0.0028
178 CHOLECYSTITIS CHRONIC 19 0.0028
179 SQUAMOUS CELL CARCINOMA OF SKIN 17 0.0028
180 END STAGE RENAL DISEASE 51 0.0028
181 OBSTRUCTION 11 0.0028
182 VIRAL UPPER RESPIRATORY TRACT INFECTION 13 0.0027
183 SPINAL OSTEOARTHRITIS 24 0.0027
184 INTESTINAL ISCHAEMIA 15 0.0027
185 IMMUNE-MEDIATED ENTEROCOLITIS 10 0.0027
186 INTERVERTEBRAL DISC DEGENERATION 25 0.0027
187 BLOOD ALKALINE PHOSPHATASE INCREASED 67 0.0027
188 BASAL CELL CARCINOMA 42 0.0027
189 VITAMIN D DECREASED 23 0.0027
190 DIARRHOEA 1735 0.0027
191 HYPERLIPIDAEMIA 32 0.0027
192 HEPATIC CYST 9 0.0026
193 BLOOD ALBUMIN DECREASED 21 0.0026
194 GALLBLADDER DISORDER 47 0.0026
195 HAEMATOCRIT DECREASED 52 0.0026
196 DRUG SPECIFIC ANTIBODY PRESENT 17 0.0026
197 HEPATIC ENZYME ABNORMAL 13 0.0026
198 GASTROENTERITIS 38 0.0026
199 POLYP 17 0.0026
200 BLOOD POTASSIUM DECREASED 78 0.0026
201 POST PROCEDURAL INFECTION 21 0.0026
202 NEPHROLITHIASIS 118 0.0026
203 UMBILICAL HERNIA 12 0.0026
204 APPETITE DISORDER 17 0.0026
205 GASTROINTESTINAL PAIN 28 0.0025
206 ELECTROLYTE IMBALANCE 29 0.0025
207 DIVERTICULITIS 69 0.0025
208 HERNIA 48 0.0025
209 CHOLECYSTITIS ACUTE 14 0.0025
210 INTERNATIONAL NORMALISED RATIO DECREASED 10 0.0025
211 GASTROINTESTINAL MOTILITY DISORDER 13 0.0024
212 HYPOKALAEMIA 112 0.0024
213 RED CELL DISTRIBUTION WIDTH INCREASED 10 0.0024
214 INFUSION SITE PAIN 31 0.0024
215 BLOOD PRESSURE FLUCTUATION 57 0.0024
216 FAECALOMA 13 0.0024
217 ABDOMINAL PAIN 551 0.0024
218 INCONTINENCE 25 0.0024
219 UVEITIS 32 0.0024
220 CHOKING 46 0.0024
221 TONGUE DISCOMFORT 10 0.0024
222 TOOTH INFECTION 31 0.0023
223 HYPOALBUMINAEMIA 18 0.0023
224 ABDOMINAL DISTENSION 241 0.0023
225 JAUNDICE 62 0.0023
226 MULTIPLE ALLERGIES 18 0.0023
227 THROAT IRRITATION 103 0.0023
228 INTENTIONAL PRODUCT USE ISSUE 201 0.0023
229 FAECAL INCONTINENCE 11 0.0023
230 IRON DEFICIENCY ANAEMIA 21 0.0023
231 DEHYDRATION 302 0.0023
232 GENERALISED OEDEMA 28 0.0023
233 AZOTAEMIA 9 0.0023
234 CHRONIC KIDNEY DISEASE 171 0.0022
235 APPENDICITIS 21 0.0022
236 OSTEOPENIA 34 0.0022
237 FLANK PAIN 21 0.0022
238 OROPHARYNGEAL PAIN 207 0.0022
239 ANEURYSM 11 0.0022
240 GLOMERULAR FILTRATION RATE DECREASED 27 0.0022
241 HAEMOGLOBIN INCREASED 10 0.0022
242 THERAPEUTIC PRODUCT EFFECT DELAYED 10 0.0022
243 PLEURISY 13 0.0022
244 RECTAL HAEMORRHAGE 94 0.0022
245 ODYNOPHAGIA 13 0.0022
246 ATELECTASIS 21 0.0022
247 HEART RATE DECREASED 76 0.0022
248 AUTOIMMUNE HEPATITIS 15 0.0022
249 BLOOD PRESSURE SYSTOLIC INCREASED 42 0.0022
250 ABSCESS 34 0.0021
251 HEPATIC PAIN 9 0.0021
252 BLOOD IRON DECREASED 25 0.0021
253 METASTASIS 15 0.0021
254 INSURANCE ISSUE 32 0.0021
255 POLYARTHRITIS 11 0.0021
256 CHOLESTASIS 40 0.0021
257 PRE-EXISTING CONDITION IMPROVED 13 0.0021
258 MUSCLE STRAIN 18 0.0021
259 POSTOPERATIVE WOUND INFECTION 14 0.0021
260 COAGULOPATHY 34 0.0020
261 BLOOD BILIRUBIN INCREASED 55 0.0020
262 HAEMATOCHEZIA 112 0.0020
263 ARTHROPOD BITE 15 0.0020
264 MUCOUS STOOLS 10 0.0020
265 INFUSION SITE ERYTHEMA 17 0.0020
266 CHOLECYSTITIS 24 0.0020
267 CYSTITIS 64 0.0020
268 SKIN CANCER 43 0.0020
269 GASTROENTERITIS VIRAL 36 0.0020
270 LIPASE INCREASED 15 0.0020
271 INCREASED TENDENCY TO BRUISE 18 0.0020
272 CONSTIPATION 415 0.0019
273 ABDOMINAL PAIN LOWER 48 0.0019
274 GASTROINTESTINAL INFECTION 17 0.0019
275 LOWER GASTROINTESTINAL HAEMORRHAGE 14 0.0019
276 EOSINOPHILIA 33 0.0019
277 WEIGHT DECREASED 522 0.0019
278 UPPER RESPIRATORY TRACT INFECTION 86 0.0019
279 GAMMA-GLUTAMYLTRANSFERASE INCREASED 41 0.0018
280 BLOOD POTASSIUM INCREASED 30 0.0018
281 INFLAMMATORY BOWEL DISEASE 18 0.0018
282 ASCITES 54 0.0018
283 COELIAC DISEASE 18 0.0018
284 TENDERNESS 19 0.0018
285 NOCTURIA 22 0.0018
286 RED BLOOD CELL SEDIMENTATION RATE INCREASED 20 0.0018
287 HYPERNATRAEMIA 9 0.0018
288 INFLAMMATION 93 0.0018
289 PELVIC FRACTURE 14 0.0018
290 SKIN MASS 12 0.0018
291 INTESTINAL PERFORATION 20 0.0018
292 BLOOD CALCIUM DECREASED 20 0.0018
293 COVID-19 PNEUMONIA 21 0.0018
294 AMMONIA INCREASED 9 0.0018
295 GASTROOESOPHAGEAL REFLUX DISEASE 142 0.0018
296 ABNORMAL LOSS OF WEIGHT 12 0.0018
297 MOUTH ULCERATION 37 0.0018
298 DEVICE RELATED INFECTION 27 0.0018
299 FAECES DISCOLOURED 38 0.0018
300 PRODUCTIVE COUGH 83 0.0017
301 ACUTE KIDNEY INJURY 266 0.0017
302 MUSCLE ATROPHY 22 0.0017
303 HERPES VIRUS INFECTION 10 0.0017
304 LARGE INTESTINE PERFORATION 12 0.0017
305 GOUT 31 0.0017
306 PRODUCT DISTRIBUTION ISSUE 16 0.0017
307 RALES 10 0.0017
308 POST PROCEDURAL COMPLICATION 33 0.0017
309 URINARY TRACT INFECTION 293 0.0017
310 ECONOMIC PROBLEM 26 0.0017
311 JOINT STIFFNESS 45 0.0017
312 ROTATOR CUFF SYNDROME 22 0.0017
313 SPLENOMEGALY 20 0.0017
314 NIGHT SWEATS 55 0.0017
315 COMPRESSION FRACTURE 9 0.0017
316 CONCUSSION 13 0.0017
317 RED BLOOD CELL COUNT DECREASED 48 0.0017
318 GINGIVITIS 9 0.0017
319 ACUTE RESPIRATORY FAILURE 32 0.0017
320 GASTROINTESTINAL DISORDER 149 0.0017
321 HYPERBILIRUBINAEMIA 17 0.0016
322 FULL BLOOD COUNT DECREASED 33 0.0016
323 ULCER 26 0.0016
324 MYOPATHY 14 0.0016
325 RENAL FAILURE 215 0.0016
326 EAR INFECTION 43 0.0016
327 BLOOD PRESSURE INCREASED 246 0.0016
328 BRONCHITIS 119 0.0016
329 ECCHYMOSIS 11 0.0016
330 OSTEOMYELITIS 29 0.0016
331 URINE OUTPUT DECREASED 14 0.0016
332 IMPAIRED QUALITY OF LIFE 23 0.0016
333 GROIN PAIN 14 0.0016
334 EYE INFECTION 18 0.0016
335 RHINORRHOEA 103 0.0016
336 HEART RATE IRREGULAR 36 0.0016
337 HICCUPS 13 0.0016
338 ORAL DISCOMFORT 22 0.0016
339 SPUTUM DISCOLOURED 15 0.0016
340 ALANINE AMINOTRANSFERASE INCREASED 97 0.0016
341 SCAR 27 0.0016
342 DRY THROAT 16 0.0016
343 ASPARTATE AMINOTRANSFERASE INCREASED 83 0.0016
344 ENTEROCOLITIS 9 0.0016
345 BLOOD URIC ACID INCREASED 9 0.0016
346 GASTRITIS 41 0.0016
347 DYSPEPSIA 153 0.0016
348 SINUS CONGESTION 21 0.0016
349 PANCREATITIS 82 0.0015
350 TENDONITIS 24 0.0015
351 LIVER FUNCTION TEST ABNORMAL 45 0.0015
352 ARTHRALGIA 643 0.0015
353 PRODUCT SUPPLY ISSUE 11 0.0015
354 THERAPEUTIC RESPONSE SHORTENED 51 0.0015
355 WHEEZING 91 0.0015
356 BRAIN FOG 24 0.0015
357 HEPATOMEGALY 15 0.0015
358 OXYGEN SATURATION DECREASED 85 0.0015
359 PLASMA CELL MYELOMA 59 0.0015
360 BLADDER DISORDER 15 0.0015
361 SCIATICA 24 0.0015
362 UTERINE LEIOMYOMA 11 0.0015
363 NECK PAIN 84 0.0015
364 OVARIAN CYST 15 0.0015
365 HAEMOGLOBIN DECREASED 154 0.0015
366 MIDDLE INSOMNIA 28 0.0015
367 BREAST MASS 10 0.0015
368 HYPOPHOSPHATAEMIA 11 0.0015
369 MICTURITION URGENCY 17 0.0015
370 SQUAMOUS CELL CARCINOMA 14 0.0015
371 COLITIS ISCHAEMIC 10 0.0015
372 FUNGAL INFECTION 49 0.0015
373 GENERAL SYMPTOM 11 0.0015
374 SLEEP APNOEA SYNDROME 28 0.0015
375 NEUTROPHIL COUNT INCREASED 15 0.0015
376 SUPRAVENTRICULAR TACHYCARDIA 14 0.0015
377 NEUROPATHY PERIPHERAL 139 0.0015
378 SKIN LESION 40 0.0015
379 JOINT EFFUSION 10 0.0014
380 LYMPHADENOPATHY 51 0.0014
381 HYPOTHYROIDISM 46 0.0014
382 OSTEOARTHRITIS 61 0.0014
383 RENAL FAILURE ACUTE 61 0.0014
384 THROMBOTIC MICROANGIOPATHY 14 0.0014
385 EXTRASYSTOLES 10 0.0014
386 EXOSTOSIS 13 0.0014
387 LABORATORY TEST ABNORMAL 42 0.0014
388 SKIN PLAQUE 12 0.0014
389 MITRAL VALVE INCOMPETENCE 16 0.0014
390 BLOOD THYROID STIMULATING HORMONE INCREASED 13 0.0014
391 ARTHRITIS 111 0.0014
392 OSTEOPOROSIS 58 0.0014
393 NERVE COMPRESSION 13 0.0014
394 DECREASED APPETITE 327 0.0014
395 OEDEMA PERIPHERAL 171 0.0014
396 CONTUSION 135 0.0014
397 NEUTROPENIC SEPSIS 10 0.0014
398 LIMB INJURY 38 0.0014
399 ERUCTATION 27 0.0014
400 SINUSITIS 143 0.0014
401 RASH MACULO-PAPULAR 31 0.0014
402 PULMONARY HYPERTENSION 29 0.0014
403 DECREASED ACTIVITY 15 0.0014
404 LIMB DISCOMFORT 43 0.0014
405 PYELONEPHRITIS 12 0.0014
406 RASH PAPULAR 31 0.0014
407 RESPIRATORY TRACT INFECTION 36 0.0014
408 ARTERIOSCLEROSIS 13 0.0014
409 COUGH 387 0.0014
410 BACK INJURY 15 0.0014
411 HYPOCALCAEMIA 26 0.0014
412 OESOPHAGITIS 15 0.0014
413 WOUND INFECTION 15 0.0014
414 BACK PAIN 317 0.0014
415 SKIN ULCER 35 0.0014
416 FOOT DEFORMITY 15 0.0014
417 RESPIRATORY RATE INCREASED 12 0.0014
418 DECUBITUS ULCER 11 0.0013
419 NERVE INJURY 15 0.0013
420 BACTERAEMIA 16 0.0013
421 THERAPY PARTIAL RESPONDER 21 0.0013
422 RASH MACULAR 47 0.0013
423 NASAL CONGESTION 79 0.0013
424 POLYURIA 11 0.0013
425 MUSCLE SPASMS 246 0.0013
426 HERPES ZOSTER 77 0.0013
427 HYPERAESTHESIA 11 0.0013
428 MUSCULOSKELETAL DISCOMFORT 23 0.0013
429 UPPER-AIRWAY COUGH SYNDROME 11 0.0013
430 WRIST FRACTURE 16 0.0013
431 PANCREATITIS ACUTE 30 0.0013
432 OEDEMA 72 0.0013
433 HEPATIC ENZYME INCREASED 90 0.0013
434 COLITIS ULCERATIVE 59 0.0013
435 PREMATURE DELIVERY 21 0.0013
436 SEPSIS 147 0.0013
437 PRODUCT AVAILABILITY ISSUE 30 0.0013
438 LIGAMENT SPRAIN 13 0.0013
439 TROPONIN INCREASED 10 0.0013
440 HYPERKALAEMIA 46 0.0013
441 CELLULITIS 66 0.0013
442 DRUG-INDUCED LIVER INJURY 41 0.0013
443 MULTIPLE ORGAN DYSFUNCTION SYNDROME 37 0.0013
444 HIP FRACTURE 42 0.0013
445 TOOTH DISORDER 29 0.0013
446 PLATELET COUNT INCREASED 17 0.0013
447 CANDIDA INFECTION 22 0.0013
448 BLOOD TRIGLYCERIDES INCREASED 23 0.0013
449 DYSPNOEA EXERTIONAL 49 0.0013
450 PERIPHERAL SWELLING 200 0.0013
451 PHARYNGITIS STREPTOCOCCAL 14 0.0013
452 THROMBOSIS 104 0.0013
453 ABDOMINAL PAIN UPPER 266 0.0013
454 ORAL CANDIDIASIS 17 0.0013
455 TOXIC SKIN ERUPTION 13 0.0013
456 OFF LABEL USE 1127 0.0013
457 CARPAL TUNNEL SYNDROME 18 0.0013
458 TINNITUS 59 0.0013
459 PSEUDOMONAS INFECTION 11 0.0013
460 ILLNESS 132 0.0013
461 TOOTH ABSCESS 13 0.0013
462 LACERATION 12 0.0013
463 DUODENAL ULCER 9 0.0013
464 PULMONARY MASS 19 0.0013
465 ELECTROCARDIOGRAM ABNORMAL 10 0.0013
466 PRODUCT ADMINISTRATION INTERRUPTED 10 0.0013
467 EYE HAEMORRHAGE 17 0.0013
468 ATRIAL FIBRILLATION 124 0.0013
469 INFLUENZA 142 0.0013
470 CARDIAC MURMUR 11 0.0013
471 HAND FRACTURE 9 0.0013
472 TOOTH FRACTURE 14 0.0013
473 DENTAL CARIES 14 0.0013
474 HEAD INJURY 40 0.0013
475 ENCEPHALOPATHY 31 0.0013
476 FURUNCLE 10 0.0013
477 RESPIRATORY TRACT CONGESTION 20 0.0013
478 LIVER FUNCTION TEST INCREASED 27 0.0013
479 GINGIVAL PAIN 10 0.0013
480 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 226 0.0013
481 ASTHENIA 470 0.0012
482 CATARACT 74 0.0012
483 TRANSFUSION 13 0.0012
484 BURSITIS 15 0.0012
485 EAR PAIN 24 0.0012
486 BLOOD PRESSURE DECREASED 82 0.0012
487 ABDOMINAL DISCOMFORT 207 0.0012
488 NASOPHARYNGITIS 227 0.0012
489 DYSPHONIA 72 0.0012
490 SHOCK HAEMORRHAGIC 10 0.0012
491 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 64 0.0012
492 MYOSITIS 11 0.0012
493 MENTAL STATUS CHANGES 34 0.0012
494 VITREOUS FLOATERS 12 0.0012
495 PNEUMONIA 395 0.0012
496 RASH PRURITIC 66 0.0012
497 WHITE BLOOD CELL COUNT DECREASED 132 0.0012
498 BODY HEIGHT DECREASED 13 0.0012
499 RESTLESS LEGS SYNDROME 22 0.0012
500 ORTHOSTATIC HYPOTENSION 21 0.0012
501 HYDRONEPHROSIS 9 0.0012
502 RENAL DISORDER 56 0.0012
503 DYSPHAGIA 114 0.0012
504 PAIN IN JAW 34 0.0012
505 BLOOD LACTATE DEHYDROGENASE INCREASED 19 0.0012
506 PNEUMONIA BACTERIAL 11 0.0012
507 PREMATURE BABY 36 0.0012
508 PROCEDURAL PAIN 33 0.0012
509 CONDITION AGGRAVATED 361 0.0012
510 AORTIC ANEURYSM 9 0.0012
511 DEMENTIA 33 0.0012
512 ANHEDONIA 31 0.0012
513 THERAPY NON-RESPONDER 53 0.0012
514 FATIGUE 916 0.0012
515 EATING DISORDER 25 0.0012
516 TUBULOINTERSTITIAL NEPHRITIS 22 0.0012
517 HYPOPHAGIA 30 0.0012
518 PLATELET COUNT DECREASED 125 0.0012
519 PRODUCT CONTAINER ISSUE 10 0.0012
520 CARDIAC OPERATION 10 0.0012
521 TEMPERATURE INTOLERANCE 12 0.0012
522 LOW DENSITY LIPOPROTEIN INCREASED 9 0.0012
523 SINUS DISORDER 23 0.0012
524 LEUKOCYTOSIS 21 0.0012
525 FOOT FRACTURE 22 0.0012
526 MYALGIA 196 0.0012
527 POLLAKIURIA 48 0.0011
528 RESPIRATORY SYNCYTIAL VIRUS INFECTION 10 0.0011
529 SKIN HAEMORRHAGE 17 0.0011
530 VOMITING 538 0.0011
531 PRODUCT PHYSICAL ISSUE 23 0.0011
532 DEEP VEIN THROMBOSIS 74 0.0011
533 INJECTION SITE EXTRAVASATION 14 0.0011
534 FEEDING DISORDER 23 0.0011
535 IMMUNOSUPPRESSION 10 0.0011
536 INFUSION RELATED REACTION 75 0.0011
537 AUTOIMMUNE DISORDER 11 0.0011
538 HEPATIC FAILURE 34 0.0011
539 THROMBOCYTOPENIA 126 0.0011
540 TRANSIENT ISCHAEMIC ATTACK 38 0.0011
541 COVID-19 197 0.0011
542 ANAEMIA 214 0.0011
543 PRODUCT USE IN UNAPPROVED INDICATION 278 0.0011
544 FALL 371 0.0011
545 MUSCLE DISORDER 9 0.0011
546 BALANCE DISORDER 96 0.0011
547 PRURITUS GENERALISED 24 0.0011
548 CHROMATURIA 25 0.0011
549 GASTRIC DISORDER 38 0.0011
550 PAIN IN EXTREMITY 326 0.0011
551 GASTRIC ULCER 21 0.0011
552 TOOTHACHE 20 0.0011
553 DYSGEUSIA 82 0.0011
554 LUPUS-LIKE SYNDROME 10 0.0011
555 FLUID RETENTION 56 0.0011
556 ANKLE FRACTURE 17 0.0011
557 SPINAL FRACTURE 22 0.0011
558 INTERVERTEBRAL DISC PROTRUSION 24 0.0011
559 DRUG INTOLERANCE 106 0.0011
560 TASTE DISORDER 22 0.0011
561 LOCALISED INFECTION 26 0.0011
562 NODULE 14 0.0011
563 ORAL PAIN 24 0.0011
564 SNEEZING 24 0.0011
565 FIBROMYALGIA 26 0.0011
566 MUCOSAL INFLAMMATION 28 0.0011
567 RESTLESSNESS 39 0.0011
568 GASTROINTESTINAL HAEMORRHAGE 89 0.0011
569 BLOOD SODIUM DECREASED 20 0.0011
570 HEART RATE INCREASED 105 0.0011
571 SENSORY DISTURBANCE 17 0.0011
572 SPINAL DISORDER 10 0.0011
573 TOXIC EPIDERMAL NECROLYSIS 16 0.0011
574 PLEURAL EFFUSION 64 0.0011
575 NAUSEA 832 0.0011
576 EYE INFLAMMATION 10 0.0010
577 PHARYNGITIS 13 0.0010
578 MALIGNANT MELANOMA 14 0.0010
579 C-REACTIVE PROTEIN INCREASED 38 0.0010
580 UNEVALUABLE EVENT 79 0.0010
581 QUALITY OF LIFE DECREASED 14 0.0010
582 CHILLS 121 0.0010
583 ECZEMA 54 0.0010
584 POST PROCEDURAL HAEMORRHAGE 12 0.0010
585 STAPHYLOCOCCAL INFECTION 34 0.0010
586 BLOOD CHOLESTEROL INCREASED 48 0.0010
587 EPISTAXIS 77 0.0010
588 NEURALGIA 25 0.0010
589 SPINAL PAIN 12 0.0010
590 PRURITUS 393 0.0010
591 NEUTROPENIA 139 0.0010
592 VIRAL INFECTION 34 0.0010
593 KIDNEY INFECTION 20 0.0010
594 JOINT SWELLING 123 0.0010
595 INTERNATIONAL NORMALISED RATIO INCREASED 29 0.0010
596 BLOOD UREA INCREASED 17 0.0010
597 AMNESIA 66 0.0010
598 HYPERSOMNIA 29 0.0010
599 SKIN LACERATION 11 0.0010
600 UPPER GASTROINTESTINAL HAEMORRHAGE 17 0.0010
601 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 26 0.0010
602 UPPER LIMB FRACTURE 20 0.0010
603 BLOOD TEST ABNORMAL 14 0.0010
604 HOT FLUSH 75 0.0010
605 INCREASED APPETITE 19 0.0010
606 FLUSHING 101 0.0010
607 EMPHYSEMA 10 0.0010
608 WHITE BLOOD CELL COUNT INCREASED 38 0.0010
609 BLOOD COUNT ABNORMAL 15 0.0010
610 PULMONARY CONGESTION 13 0.0010
611 EYELID PTOSIS 10 0.0010
612 JOINT INJURY 21 0.0010
613 IMPAIRED WORK ABILITY 21 0.0010
614 SKIN INFECTION 11 0.0010
615 FEELING HOT 60 0.0010
616 RENAL INJURY 29 0.0010
617 WEIGHT INCREASED 218 0.0010
618 ORAL HERPES 19 0.0010
619 RIB FRACTURE 20 0.0010
620 SKIN FISSURES 19 0.0010
621 CONJUNCTIVITIS 18 0.0010
622 IMPAIRED DRIVING ABILITY 11 0.0010
623 BACTERIAL INFECTION 18 0.0010
624 DERMATITIS CONTACT 11 0.0010
625 DYSPNOEA 539 0.0010
626 GINGIVAL BLEEDING 13 0.0010
627 SCRATCH 10 0.0009
628 CARDIOMYOPATHY 14 0.0009
629 URINARY INCONTINENCE 28 0.0009
630 DRUG EFFECT LESS THAN EXPECTED 14 0.0009
631 VASCULITIS 11 0.0009
632 IMPAIRED HEALING 31 0.0009
633 PYREXIA 326 0.0009
634 PULMONARY OEDEMA 42 0.0009
635 GLAUCOMA 18 0.0009
636 DISCOMFORT 57 0.0009
637 BONE DISORDER 17 0.0009
638 HYPERCHOLESTEROLAEMIA 9 0.0009
639 APHONIA 13 0.0009
640 MASS 13 0.0009
641 HAEMATOMA 24 0.0009
642 PRODUCT USE ISSUE 174 0.0009
643 MALAISE 406 0.0009
644 HYPERTENSION 196 0.0009
645 MUSCULOSKELETAL STIFFNESS 81 0.0009
646 DYSURIA 34 0.0009
647 HEADACHE 578 0.0009
648 MIGRAINE 88 0.0009
649 PNEUMONIA ASPIRATION 23 0.0009
650 NEOPLASM PROGRESSION 32 0.0009
651 NERVOUSNESS 48 0.0009
652 PALLOR 25 0.0009
653 PULMONARY THROMBOSIS 10 0.0009
654 EYE DISORDER 30 0.0009
655 INSOMNIA 243 0.0009
656 DRY MOUTH 74 0.0009
657 HOSPICE CARE 9 0.0009
658 PERICARDIAL EFFUSION 21 0.0009
659 METABOLIC ACIDOSIS 29 0.0009
660 DERMATITIS 19 0.0009
661 MUSCULAR WEAKNESS 103 0.0009
662 SWELLING FACE 59 0.0009
663 INFLUENZA LIKE ILLNESS 74 0.0009
664 HYPONATRAEMIA 50 0.0009
665 CYST 11 0.0009
666 LOWER LIMB FRACTURE 17 0.0009
667 EPILEPSY 27 0.0009
668 HYPOXIA 31 0.0009
669 SCAB 10 0.0009
670 PANCYTOPENIA 49 0.0009
671 CORONARY ARTERY OCCLUSION 12 0.0009
672 BLOOD CREATININE INCREASED 57 0.0009
673 MOVEMENT DISORDER 28 0.0009
674 RESPIRATORY DISTRESS 24 0.0009
675 CHEST PAIN 161 0.0009
676 EXPOSURE DURING PREGNANCY 54 0.0009
677 TOOTH LOSS 18 0.0009
678 ARTHROPATHY 48 0.0009
679 MELAENA 19 0.0009
680 SYNCOPE 86 0.0009
681 CARDIAC FAILURE CONGESTIVE 69 0.0009
682 NEEDLE ISSUE 25 0.0009
683 WOUND 24 0.0009
684 LIVER DISORDER 38 0.0009
685 SEPTIC SHOCK 37 0.0008
686 THROAT TIGHTNESS 23 0.0008
687 SKIN DISCOLOURATION 39 0.0008
688 PRODUCT DOSE OMISSION IN ERROR 24 0.0008
689 DIALYSIS 12 0.0008
690 BLOOD URINE PRESENT 16 0.0008
691 INTENTIONAL DOSE OMISSION 24 0.0008
692 BURNING SENSATION 59 0.0008
693 LYMPHOMA 13 0.0008
694 MUSCULOSKELETAL PAIN 44 0.0008
695 ANXIETY 239 0.0008
696 URINARY RETENTION 28 0.0008
697 CEREBROVASCULAR ACCIDENT 142 0.0008
698 MACULAR DEGENERATION 10 0.0008
699 CARDIOGENIC SHOCK 12 0.0008
700 POOR QUALITY SLEEP 18 0.0008
701 LETHARGY 48 0.0008
702 BLOOD CREATINE PHOSPHOKINASE INCREASED 24 0.0008
703 EYE SWELLING 31 0.0008
704 HYPOTENSION 167 0.0008
705 PRODUCT DOSE OMISSION ISSUE 242 0.0008
706 PRESYNCOPE 20 0.0008
707 ASPIRATION 9 0.0008
708 HEPATITIS 21 0.0008
709 JOINT RANGE OF MOTION DECREASED 11 0.0008
710 PALPITATIONS 96 0.0008
711 BONE PAIN 48 0.0008
712 DEPRESSION 186 0.0008
713 CARDIOMEGALY 10 0.0008
714 SPINAL OPERATION 10 0.0008
715 GAIT DISTURBANCE 155 0.0008
716 SKIN DISORDER 27 0.0008
717 STOMATITIS 49 0.0008
718 PAIN 495 0.0008
719 FEELING ABNORMAL 193 0.0008
720 IMMUNODEFICIENCY 12 0.0008
721 ACUTE HEPATIC FAILURE 11 0.0008
722 BLOOD PRESSURE ABNORMAL 16 0.0008
723 TREATMENT NONCOMPLIANCE 44 0.0008
724 HYPOGLYCAEMIA 39 0.0008
725 DEAFNESS 21 0.0008
726 MUSCLE TIGHTNESS 13 0.0008
727 SURGERY 47 0.0008
728 SECRETION DISCHARGE 10 0.0008
729 HYPOAESTHESIA 119 0.0008
730 APHASIA 24 0.0008
731 PRODUCT ADMINISTRATION ERROR 16 0.0008
732 CHEST DISCOMFORT 81 0.0008
733 HAEMATURIA 27 0.0008
734 DIZZINESS 393 0.0008
735 DYSKINESIA 32 0.0008
736 RENAL IMPAIRMENT 66 0.0008
737 MENTAL IMPAIRMENT 19 0.0008
738 NEOPLASM 9 0.0008
739 MUSCLE TWITCHING 18 0.0008
740 ANAPHYLACTIC REACTION 43 0.0008
741 EYELID OEDEMA 9 0.0008
742 LIVER INJURY 19 0.0008
743 EJECTION FRACTION DECREASED 12 0.0008
744 PARAESTHESIA 121 0.0008
745 RESPIRATORY DISORDER 23 0.0008
746 CONFUSIONAL STATE 124 0.0008
747 BLISTER 43 0.0008
748 TREMOR 127 0.0008
749 BEDRIDDEN 10 0.0008
750 INJECTION SITE HAEMATOMA 11 0.0008
751 THERAPEUTIC RESPONSE UNEXPECTED 34 0.0008
752 PULMONARY EMBOLISM 72 0.0008
753 RASH 329 0.0008
754 RASH ERYTHEMATOUS 36 0.0008
755 CYTOKINE RELEASE SYNDROME 15 0.0007
756 HAIR TEXTURE ABNORMAL 10 0.0007
757 DRY EYE 37 0.0007
758 INFECTION 107 0.0007
759 COLD SWEAT 13 0.0007
760 HYPERHIDROSIS 95 0.0007
761 UNRESPONSIVE TO STIMULI 19 0.0007
762 LYMPHOCYTE COUNT DECREASED 13 0.0007
763 BODY TEMPERATURE INCREASED 15 0.0007
764 URTICARIA 122 0.0007
765 LACRIMATION INCREASED 22 0.0007
766 OSTEONECROSIS OF JAW 18 0.0007
767 DRUG INEFFECTIVE 958 0.0007
768 VENTRICULAR TACHYCARDIA 12 0.0007
769 FOETAL EXPOSURE DURING PREGNANCY 59 0.0007
770 DRUG LEVEL INCREASED 12 0.0007
771 FEBRILE NEUTROPENIA 48 0.0007
772 HEPATIC FUNCTION ABNORMAL 27 0.0007
773 AGEUSIA 18 0.0007
774 DYSARTHRIA 27 0.0007
775 HYPERGLYCAEMIA 26 0.0007
776 INJURY 50 0.0007
777 DEVICE OCCLUSION 10 0.0007
778 HAEMATEMESIS 18 0.0007
779 GENERAL PHYSICAL HEALTH DETERIORATION 82 0.0007
780 HEMIPARESIS 12 0.0007
781 HAEMORRHAGE 74 0.0007
782 ASTHMA 80 0.0007
783 ACTIVITIES OF DAILY LIVING IMPAIRED 14 0.0007
784 VERTIGO 43 0.0007
785 INTRAOCULAR PRESSURE INCREASED 9 0.0007
786 BONE DENSITY DECREASED 22 0.0007
787 MOBILITY DECREASED 50 0.0007
788 MATERNAL EXPOSURE DURING PREGNANCY 62 0.0007
789 LUNG DISORDER 34 0.0007
790 MYELODYSPLASTIC SYNDROME 10 0.0007
791 OBESITY 11 0.0007
792 HYPERSENSITIVITY 128 0.0007
793 HYPOKINESIA 10 0.0007
794 PRODUCT PRESCRIBING ISSUE 15 0.0007
795 GAIT INABILITY 23 0.0007
796 LOCAL SWELLING 12 0.0007
797 FLUID OVERLOAD 10 0.0007
798 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 16 0.0007
799 MUSCULOSKELETAL DISORDER 13 0.0007
800 METASTASES TO LIVER 12 0.0007
801 BRADYCARDIA 36 0.0007
802 HEAD DISCOMFORT 12 0.0007
803 DIABETES MELLITUS INADEQUATE CONTROL 12 0.0007
804 BACK DISORDER 11 0.0007
805 TRANSAMINASES INCREASED 15 0.0007
806 ROAD TRAFFIC ACCIDENT 28 0.0007
807 FEAR 18 0.0007
808 SPEECH DISORDER 35 0.0007
809 ALOPECIA 131 0.0007
810 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 32 0.0007
811 PHOTOSENSITIVITY REACTION 11 0.0007
812 SLEEP DISORDER 47 0.0007
813 ANGINA PECTORIS 19 0.0007
814 LIP SWELLING 22 0.0007
815 DIPLOPIA 17 0.0007
816 HIP ARTHROPLASTY 10 0.0007
817 SHOCK 15 0.0007
818 DYSSTASIA 19 0.0007
819 PHARYNGEAL OEDEMA 10 0.0006
820 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 19 0.0006
821 MEMORY IMPAIRMENT 89 0.0006
822 HUNGER 9 0.0006
823 AGRANULOCYTOSIS 12 0.0006
824 BLOOD GLUCOSE DECREASED 31 0.0006
825 COORDINATION ABNORMAL 9 0.0006
826 RESPIRATORY FAILURE 47 0.0006
827 ACUTE MYOCARDIAL INFARCTION 19 0.0006
828 INCORRECT DOSE ADMINISTERED 147 0.0006
829 LUNG INFECTION 10 0.0006
830 VISION BLURRED 88 0.0006
831 LEUKOPENIA 32 0.0006
832 CYANOSIS 10 0.0006
833 ERYTHEMA 130 0.0006
834 PAIN OF SKIN 17 0.0006
835 BRONCHOSPASM 9 0.0006
836 HALLUCINATION, AUDITORY 10 0.0006
837 EYE PRURITUS 21 0.0006
838 DEPRESSED MOOD 33 0.0006
839 DRUG INTERACTION 99 0.0006
840 EYE PAIN 35 0.0006
841 COMPLICATION ASSOCIATED WITH DEVICE 9 0.0006
842 KNEE ARTHROPLASTY 13 0.0006
843 ISCHAEMIC STROKE 11 0.0006
844 LOWER RESPIRATORY TRACT INFECTION 28 0.0006
845 THIRST 11 0.0006
846 MYOCARDIAL INFARCTION 107 0.0006
847 ARRHYTHMIA 29 0.0006
848 FEELING COLD 17 0.0006
849 DELIRIUM 21 0.0006
850 COLON CANCER 9 0.0006
851 THERAPY CESSATION 31 0.0006
852 HAEMORRHAGE INTRACRANIAL 9 0.0006
853 THERAPY INTERRUPTED 43 0.0006
854 INJECTION SITE BRUISING 48 0.0006
855 SWELLING 56 0.0006
856 VISUAL IMPAIRMENT 74 0.0006
857 INJECTION SITE MASS 22 0.0006
858 ADVERSE DRUG REACTION 53 0.0006
859 PRODUCT PRESCRIBING ERROR 14 0.0006
860 PHOTOPHOBIA 11 0.0006
861 HEPATOTOXICITY 13 0.0006
862 INJECTION SITE WARMTH 12 0.0006
863 DISEASE PROGRESSION 69 0.0006
864 GLOSSODYNIA 13 0.0006
865 RASH GENERALISED 15 0.0006
866 PHARMACEUTICAL PRODUCT COMPLAINT 15 0.0006
867 LOSS OF CONSCIOUSNESS 74 0.0006
868 ACUTE MYELOID LEUKAEMIA 9 0.0006
869 THERAPEUTIC RESPONSE DECREASED 35 0.0006
870 DRY SKIN 77 0.0006
871 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 41 0.0006
872 SYRINGE ISSUE 10 0.0006
873 PRODUCT DOSE OMISSION 37 0.0006
874 DIABETES MELLITUS 43 0.0006
875 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 40 0.0006
876 CORONARY ARTERY DISEASE 17 0.0006
877 COGNITIVE DISORDER 26 0.0006
878 MALIGNANT NEOPLASM PROGRESSION 57 0.0006
879 SOMNOLENCE 112 0.0006
880 GLYCOSYLATED HAEMOGLOBIN INCREASED 14 0.0006
881 MULTIPLE SCLEROSIS RELAPSE 38 0.0006
882 HOSPITALISATION 85 0.0006
883 RHABDOMYOLYSIS 23 0.0006
884 PELVIC PAIN 10 0.0005
885 ABORTION SPONTANEOUS 22 0.0005
886 FEMUR FRACTURE 17 0.0005
887 NERVOUS SYSTEM DISORDER 17 0.0005
888 TREATMENT FAILURE 45 0.0005
889 BLOOD GLUCOSE ABNORMAL 10 0.0005
890 NEUTROPHIL COUNT DECREASED 22 0.0005
891 INJECTION SITE HAEMORRHAGE 43 0.0005
892 HAEMOPTYSIS 15 0.0005
893 INJECTION SITE PRURITUS 36 0.0005
894 HYPOACUSIS 23 0.0005
895 FACE OEDEMA 9 0.0005
896 CARDIAC ARREST 44 0.0005
897 INJECTION SITE ERYTHEMA 66 0.0005
898 DRUG EXPOSURE DURING PREGNANCY 18 0.0005
899 TACHYCARDIA 47 0.0005
900 OCULAR HYPERAEMIA 25 0.0005
901 DISEASE RECURRENCE 25 0.0005
902 INJECTION SITE PAIN 161 0.0005
903 MULTIPLE SCLEROSIS 25 0.0005
904 DRUG EFFECT DECREASED 28 0.0005
905 EMOTIONAL DISORDER 16 0.0005
906 PNEUMONITIS 14 0.0005
907 MOOD ALTERED 14 0.0005
908 CARDIAC DISORDER 48 0.0005
909 EXPIRED PRODUCT ADMINISTERED 17 0.0005
910 NEOPLASM MALIGNANT 34 0.0005
911 INJECTION SITE SWELLING 39 0.0005
912 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
913 SEIZURE 58 0.0005
914 BLOOD GLUCOSE INCREASED 94 0.0005
915 SKIN EXFOLIATION 42 0.0005
916 INCORRECT DRUG ADMINISTRATION DURATION 14 0.0005
917 INTERSTITIAL LUNG DISEASE 24 0.0005
918 INJECTION SITE RASH 15 0.0005
919 SUICIDAL IDEATION 44 0.0005
920 DISORIENTATION 19 0.0005
921 TYPE 2 DIABETES MELLITUS 16 0.0005
922 MEDICATION ERROR 26 0.0005
923 MENTAL DISORDER 20 0.0005
924 DEVICE ISSUE 41 0.0005
925 OSTEONECROSIS 15 0.0005
926 DISABILITY 9 0.0005
927 VISUAL ACUITY REDUCED 15 0.0005
928 SWOLLEN TONGUE 14 0.0004
929 THERAPEUTIC PRODUCT EFFECT DECREASED 20 0.0004
930 EXTRAPYRAMIDAL DISORDER 11 0.0004
931 DRUG EFFECT INCOMPLETE 16 0.0004
932 CRYING 16 0.0004
933 MOOD SWINGS 14 0.0004
934 ABNORMAL DREAMS 12 0.0004
935 EYE IRRITATION 25 0.0004
936 PSORIASIS 56 0.0004
937 HALLUCINATION 32 0.0004
938 ACNE 32 0.0004
939 EMOTIONAL DISTRESS 51 0.0004
940 PRODUCT QUALITY ISSUE 57 0.0004
941 BLINDNESS 17 0.0004
942 DEATH 359 0.0004
943 DIABETIC KETOACIDOSIS 10 0.0004
944 PANIC ATTACK 15 0.0004
945 ILL-DEFINED DISORDER 25 0.0004
946 DRUG DOSE OMISSION 68 0.0004
947 AGITATION 30 0.0004
948 RHEUMATOID ARTHRITIS 46 0.0004
949 IRRITABILITY 24 0.0004
950 SKIN BURNING SENSATION 28 0.0004
951 CARDIAC FAILURE 31 0.0004
952 CARDIO-RESPIRATORY ARREST 16 0.0004
953 LACTIC ACIDOSIS 12 0.0004
954 ADVERSE EVENT 34 0.0004
955 CONTRAINDICATED PRODUCT ADMINISTERED 11 0.0004
956 CEREBRAL HAEMORRHAGE 13 0.0004
957 COMA 17 0.0004
958 TARDIVE DYSKINESIA 10 0.0004
959 EXPOSURE VIA SKIN CONTACT 9 0.0003
960 PANCREATIC CARCINOMA 10 0.0003
961 SYSTEMIC LUPUS ERYTHEMATOSUS 12 0.0003
962 DISTURBANCE IN ATTENTION 18 0.0003
963 ELECTROCARDIOGRAM QT PROLONGED 12 0.0003
964 UNDERDOSE 24 0.0003
965 SKIN IRRITATION 15 0.0003
966 INTENTIONAL PRODUCT MISUSE 28 0.0003
967 CONVULSION 18 0.0003
968 BREAST CANCER 29 0.0003
969 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 61 0.0003
970 VAGINAL HAEMORRHAGE 13 0.0003
971 PROSTATE CANCER 24 0.0003
972 LUNG NEOPLASM MALIGNANT 12 0.0003
973 INJECTION SITE REACTION 20 0.0003
974 NIGHTMARE 10 0.0003
975 WITHDRAWAL SYNDROME 12 0.0003
976 DEPRESSED LEVEL OF CONSCIOUSNESS 11 0.0003
977 EXTRA DOSE ADMINISTERED 11 0.0003
978 DEVICE MALFUNCTION 19 0.0003
979 RENAL CANCER 12 0.0003
980 PSORIATIC ARTHROPATHY 10 0.0002
981 ACCIDENTAL OVERDOSE 9 0.0002
982 ABNORMAL BEHAVIOUR 9 0.0002
983 OVERDOSE 49 0.0002
984 NO ADVERSE EVENT 41 0.0002
985 DEVICE BREAKAGE 9 0.0002
986 AGGRESSION 9 0.0002
987 TOXICITY TO VARIOUS AGENTS 27 0.0002
988 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0002
989 DEVICE DIFFICULT TO USE 10 0.0002
990 PRODUCT STORAGE ERROR 13 0.0001
991 COMPLETED SUICIDE 12 0.0001
992 DRUG WITHDRAWAL SYNDROME 10 0.0001